anmelden
SPI
20.302,73
PKT
-134,24
PKT
-0,66
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.01.12 | Swatch (I) buy | Vontobel Research | |
| 10.01.12 | Sika buy | Vontobel Research | |
| 09.01.12 | Clariant buy | UBS AG | |
| 09.01.12 | Holcim sell | Citigroup Corp. | |
| 09.01.12 | UBS underperform | Exane-BNP Paribas SA | |
| 09.01.12 | Zurich Insurance buy | Nomura | |
| 09.01.12 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 09.01.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 09.01.12 | Novartis hold | Vontobel Research | |
| 09.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 06.01.12 | UBS overweight | J.P. Morgan Cazenove | |
| 06.01.12 | UBS overweight | J.P. Morgan Cazenove | |
| 06.01.12 | UBS outperform | RBC Capital Markets | |
| 06.01.12 | UBS buy | Nomura | |
| 06.01.12 | UBS neutral | Nomura | |
| 06.01.12 | SGS SA hold | Société Générale Group S.A. (SG) | |
| 06.01.12 | Bell buy | Vontobel Research | |
| 06.01.12 | Orior hold | Vontobel Research | |
| 05.01.12 | Novartis overweight | J.P. Morgan Cazenove | |
| 05.01.12 | Holcim neutral | Credit Suisse Group | |
| 05.01.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 05.01.12 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 05.01.12 | Arbonia hold | Vontobel Research | |
| 05.01.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 05.01.12 | Ascom hold | Vontobel Research | |
| 05.01.12 | Swatch (I) buy | Sarasin Research | |
| 04.01.12 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 04.01.12 | Givaudan sell | Deutsche Bank AG | |
| 04.01.12 | UBS hold | Deutsche Bank AG | |
| 04.01.12 | UBS hold | Deutsche Bank AG | |
| 04.01.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 04.01.12 | Jungfraubahn hold | Vontobel Research | |
| 04.01.12 | Forbo International buy | Sarasin Research | |
| 04.01.12 | Novartis buy | Deutsche Bank AG | |
| 03.01.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 03.01.12 | Roche buy | Deutsche Bank AG | |
| 03.01.12 | Adecco SA buy | Vontobel Research | |
| 03.01.12 | Orior hold | Vontobel Research | |
| 30.12.11 | Allreal neutral | Sarasin Research | |
| 27.12.11 | Novartis kaufen | Raiffeisen Centrobank AG |
